Recombinant Human RGS5 Protein，GST

RBBP4 (Retinoblastoma Binding Protein 4) is a crucial protein involved in the regulation of various cellular processes, including cell cycle control, chromatin remodeling, and gene expression. Initially identified as a binding partner of the retinoblastoma tumor suppressor protein, RBBP4 is now recognized for its role in epigenetic regulation and the maintenance of genome stability. The research surrounding RBBP4 has gained momentum due to its potential implications in cancer biology and developmental disorders. Notably, alterations in RBBP4 expression levels have been associated with various malignancies, underscoring its importance as a biomarker and potential therapeutic target. The study of recombinantly produced RBBP4 proteins enables detailed investigations into its structure-function relationships, interaction networks, and the mechanisms by which it exerts its regulatory effects. By utilizing techniques such as X-ray crystallography and nuclear magnetic resonance (NMR), researchers aim to unravel the precise molecular functions of RBBP4 and how its dysregulation contributes to oncogenic processes. Additionally, the functional characterization of RBBP4 through reconstitution experiments in cellular models provides insights into its role in chromatin dynamics and transcriptional regulation. Ultimately, the comprehensive understanding of RBBP4's mechanisms could pave the way for novel therapeutic strategies in targeting its pathways in cancer and other diseases linked to its dysfunction.